Development of paclitaxel-TyroSpheres for topical skin treatment

Journal of Controlled Release

Volumn 163, Issue 1, 2012, Pages 18-24

  Kilfoyle, Brian E ^a,b   Sheihet, Larisa ^b   Zhang, Zheng ^b   Laohoo, Marissa ^a,b   Kohn, Joachim ^b   Michniak Kohn, Bozena B ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Cytotoxicity; Psoriasis; Skin distribution; Topical drug delivery; Tyrosine derived nanospheres; Viscous formulation

Indexed keywords

ANTI-PROLIFERATIVE; BASAL LAYER; FLOW CHARACTERISTIC; HUMAN KERATINOCYTES; KERATINOCYTES; PACLITAXEL; PSORIASIS; SKIN PERMEATION; SKIN SURFACES; VISCOUS FORMULATION;

AMINO ACIDS; CYTOTOXICITY; DERMATOLOGY; DRUG DELIVERY; NANOSPHERES;

SKIN;

NANOSPHERE; PACLITAXEL; PHOSPHATE BUFFERED SALINE; TYROSINE;

CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG RELEASE; DRUG SOLUBILITY; EPIDERMIS; FLOW RATE; GEL; HUMAN; HUMAN CELL; IC 50; KERATINOCYTE; NANOENCAPSULATION; PRIORITY JOURNAL; PSORIASIS; SKIN PERMEABILITY; SKIN SURFACE; TOPICAL DRUG ADMINISTRATION; VISCOSITY;

ADMINISTRATION, CUTANEOUS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE; DRUG CARRIERS; HUMANS; NANOSPHERES; PACLITAXEL; SKIN; SKIN ABSORPTION; TYROSINE;

EID: 84866736299     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.06.021     Document Type: Conference Paper

References (34)

1. D.M. Danilenko Review paper: preclinical models of psoriasis Vet. Pathol. 45 2008 563 575
2. R.A. Clark, and T.S. Kupper Misbehaving macrophages in the pathogenesis of psoriasis J. Clin. Invest. 116 2006 2084 2087
3. Y.S. Bae, A.S. Van Voorhees, S. Hsu, N.J. Korman, M.G. Lebwohl, M. Young, B. Bebo Jr., and A.B. Kimball Review of treatment options for psoriasis in pregnant or lactating women: from the Medical Board of the National Psoriasis Foundation J. Am. Acad. Dermatol. 67 2012 459 477
4. J.M. Koziara, P.R. Lockman, D.D. Allen, and R.J. Mumper Paclitaxel nanoparticles for the potential treatment of brain tumors J. Control. Release 99 2004 259 269
5. R.T. Liggins, W.L. Hunter, and H.M. Burt Solid-state characterization of paclitaxel J. Pharm. Sci. 86 1997 1458 1463
6. P.H. Wiernik, E.L. Schwartz, J.J. Strauman, J.P. Dutcher, R.B. Lipton, and E. Paietta Phase I clinical and pharmacokinetic study of taxol Cancer Res. 47 1987 2486 2493
7. L. Mu, and S.S. Feng A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS J. Control. Release 86 2003 33 48
8. J.P. Micha, B.H. Goldstein, C.L. Birk, M.A. Rettenmaier, and J.V. Brown 3rd Abraxane in the treatment of ovarian cancer: the absence of hypersensitivity reactions Gynecol. Oncol. 100 2006 437 438
9. M.H. Bartoli, M. Boitard, H. Fessi, H. Beriel, J.P. Devissaguet, F. Picot, and F. Puisieux In vitro and in vivo antitumoral activity of free, and encapsulated taxol J. Microencapsul. 7 1990 191 197
10. B.D. Tarr, T.G. Sambandan, and S.H. Yalkowsky A new parenteral emulsion for the administration of taxol Pharm. Res. 4 1987 162 165
11. B.Y.S. Ong, S.H. Ranganath, L.Y. Lee, F. Lu, H.-W. Lee, N.V. Sahinidis, and C.-H. Wang Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme Biomaterials 30 2009 3189 3196
12. A. Ehrlich, S. Booher, Y. Becerra, D.L. Borris, W.D. Figg, M.L. Turner, and A. Blauvelt Micellar paclitaxel improves severe psoriasis in a prospective phase II pilot study J. Am. Acad. Dermatol. 50 2004 533 540
13. L. Sheihet, K. Piotrowska, R.A. Dubin, J. Kohn, and D. Devore Effect of tyrosine-derived triblock copolymer compositions on nanosphere self-assembly and drug delivery Biomacromolecules 8 2007 998 1003
14. L. Sheihet, O.B. Garbuzenko, J. Bushman, M.K. Gounder, T. Minko, and J. Kohn Paclitaxel in tyrosine-derived nanospheres as a potential anti-cancer agent: in vivo evaluation of toxicity and efficacy in comparison with paclitaxel in Cremophor Eur. J. Pharm. Sci. 45 2012 320 329
15. P. Batheja, L. Sheihet, J. Kohn, A.J. Singer, and B. Michniak-Kohn Topical drug delivery by a polymeric nanosphere gel: formulation optimization and in vitro and in vivo skin distribution studies J. Control. Release 149 2011 159 167
16. L. Sheihet, P. Chandra, P. Batheja, D. Devore, J. Kohn, and B. Michniak Tyrosine-derived nanospheres for enhanced topical skin penetration Int. J. Pharm. 350 2008 312 319
17. L. Sheihet, R.A. Dubin, D. Devore, and J. Kohn Hydrophobic drug delivery by self-assembling triblock copolymer-derived nanospheres Biomacromolecules 6 2005 2726 2731
18. G. Cumming, F. Fidler, and D.L. Vaux Error bars in experimental biology J. Cell Biol. 177 2007 7 11
19. S.L. Bourke, and J. Kohn Polymers derived from the amino acid L-tyrosine: polycarbonates, polyarylates and copolymers with poly(ethylene glycol) Adv. Drug Deliv. Rev. 55 2003 447 466
20. A.D. Costache, L. Sheihet, K. Zaveri, D.D. Knight, and J. Kohn Polymer-drug interactions in tyrosine-derived triblock copolymer nanospheres: a computational modeling approach Mol. Pharm. 6 2009 1620 1627
21. D.D. Verma, S. Verma, G. Blume, and A. Fahr Particle size of liposomes influences dermal delivery of substances into skin Int. J. Pharm. 258 2003 141 151
22. R. Alvarez-Roman, A. Naik, Y.N. Kalia, R.H. Guy, and H. Fessi Skin penetration and distribution of polymeric nanoparticles J. Control. Release 99 2004 53 62
23. B.W. Barry Novel mechanisms and devices to enable successful transdermal drug delivery Eur. J. Pharm. Sci. 14 2001 101 114
24. A.E. Mathew, M.R. Mejillano, J.P. Nath, R.H. Himes, and V.J. Stella Synthesis and evaluation of some water-soluble prodrugs and derivatives of taxol with antitumor activity J. Med. Chem. 35 1992 145 151
25. B.D. Tarr, and S.H. Yalkowsky A new parenteral vehicle for the administration of some poorly water soluble anti-cancer drugs J. Parenter. Sci. Technol. 41 1987 31 33
26. C.S. Swindell, N.E. Krauss, S.B. Horwitz, and I. Ringel Biologically active taxol analogues with deleted A-ring side chain substituents and variable C-2′ configurations J. Med. Chem. 34 1991 1176 1184
27. K. Letchford, and H. Burt A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes Eur. J. Pharm. Biopharm. 65 2007 259 269
28. P. Boukamp, R.T. Petrussevska, D. Breitkreutz, J. Hornung, A. Markham, and N.E. Fusenig Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line J. Cell Biol. 106 1988 761 771
29. O. Seleverstov, O. Zabirnyk, M. Zscharnack, L. Bulavina, M. Nowicki, J.M. Heinrich, M. Yezhelyev, F. Emmrich, R. O'Regan, and A. Bader Quantum dots for human mesenchymal stem cells labeling. A size-dependent autophagy activation Nano Lett. 6 2006 2826 2832
30. S. Al-Nasiry, N. Geusens, M. Hanssens, C. Luyten, and R. Pijnenborg The use of Alamar Blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells Hum. Reprod. 22 2007 1304 1309
31. J.J. van de Sandt, W.J. Meuling, G.R. Elliott, N.H. Cnubben, and B.C. Hakkert Comparative in vitro-in vivo percutaneous absorption of the pesticide propoxur Toxicol. Sci. 58 2000 15 22
32. T.W. Prow, J.E. Grice, L.L. Lin, R. Faye, M. Butler, W. Becker, E.M. Wurm, C. Yoong, T.A. Robertson, H.P. Soyer, and M.S. Roberts Nanoparticles and microparticles for skin drug delivery Adv. Drug Deliv. Rev. 63 2011 470 491
33. V. Sachdeva, H.D. Kim, P.M. Friden, and A.K. Banga Iontophoresis mediated in vivo intradermal delivery of terbinafine hydrochloride Int. J. Pharm. 393 2010 112 118
34. M.S. Roberts Targeted drug delivery to the skin and deeper tissues: role of physiology, solute structure and disease Clin. Exp. Pharmacol. Physiol. 24 1997 874 879